2026 Orphan Drugs Report: A safe(r) passage amid stormy waters?

FierceBiotechEntry Japan with Clarity, Execute with Confidence

Endpoints News#ASCO26: AstraZeneca's triplet combo succeeds in liver cancer subgroup

Clinical OMICsPersonalized Cancer Vaccine Reduces Melanoma Recurrence by 49%

FierceBiotechLilly locks in 5-program R&D pact with China’s Haisco worth up to $3B, but targets unclear

Endpoints NewsLilly licenses GLP-2 asset from Korean biotech Hanmi for $75M upfront

Endpoints News#ASCO26: Erleada succeeds in early-stage prostate cancer study, but questions remain

BioPharma Dive2026 Orphan Drugs Report: A safe(r) passage amid stormy waters?

FierceBiotechLilly pens $1.2B deal for Hanmi’s GLP-2 drug being aimed at short bowel syndrome

Endpoints NewsOculis’ eye drops for diabetic macular edema flunk Phase 3 test

eLifeInterplay between cohesin and TORC1 links chromosome segregation and gene expression to environmental changes

eLifeDistinct evolutionary trajectories of two integration centres, the central complex and mushroom bodies, across Heliconiini butterflies

eLifeBeta-Glucan modulates monocyte plasticity and differentiation capacity to mitigate DSS-induced colitis